Skip to main content
. 2023 Dec 23;99:104938. doi: 10.1016/j.ebiom.2023.104938

Table 1.

Demographic and outcome data by MODS trajectory in the training dataset.

Persistent mods Resolving mods no mods p-value
N (%) 46 (22.7%) 63 (31.0%) 92 (46.3%)
Age (Years) 1.8 (0.5, 4.5) 2.4 (1.1, 5.2) 2.9 (1.3, 6.1) 0.03
Sex, M 28 (60.8%) 35 (55.5%) 50 (53.2%) 0.69
Race
 White 29 (63.0%) 40 (63.5%) N/A 0.83
 Black 11 (23.9%) 18 (28.5%)
 Other 6 (13.1%) 5 (8.0%)
PRISM-III 21 (15, 29) 14 (10, 18) 1 (0, 10) 0.01
Day 1 VIS score 20 (1, 55) 10 (1, 20) 0 (0, 0) 0.07
Source
 Pulmonary 9 (20.9%) 7 (11.2%) 2 (2.2%) 0.45
 Extrapulmonary 23 (53.4%) 28 (44.4%) 7 (7.6%)
 None 14 (30.4%) 28 (44.4%) 83 (90.2%)
Pathogen type 0.66
 Gram positive 19 (59.4%) 15 (42.8%) 5 (55.5%)
 Gram negative 10 (31.0%) 15 (42.8%) 6 (66.6%)
 Viral 2 (6.6%) 4 (11.4%) 0 (0)
 Fungal 1 (3.0%) 1 (2.8%) 0 (0)
Outcomes
28-Day mortality 17 (36.9%) 1 (1.5%) 0 (0) <0.01
PICU free days 12 (0, 19) 22 (17, 24) 23 (19, 25) <0.01
PICU LOS 10 (3, 19) 6 (4, 11) 5 (3, 8) 0.02
Hospital LOS 19 (3, 33) 10 (8, 21) 9 (7, 14) 0.38
Steroid use 18 (39.2%) 15 (30.6%) 4 (4.4%) 0.38

PRISM III: Pediatric Risk of Mortality III score; VIS score: Vasoactive inotropic score; LOS: Length of stay; N/A: Not available.